NIMedical is the developer and manufacturer of the Non Invasive Cardiac System (NICaS) a non invasive hemodynamic and fluid management system. Providing ICU level hemodynamic and fluid data in a variety medical settings including primary care as well as patient home.



Our Representatives

Igor Granov

COO, NI Medical

COO

NI Medical

NIMedical is a biotechnology company, the world’s leading developer and manufacturer of whole body bioimpedance systems. The Non Invasive Cardiac System (NICaS) and the Hemodynamic Naviga...

Dana Barocas

VP Business Development, NI Medical

VP Business Development

NI Medical

Both clinical and Business oriented approach for an exceptional solution.

Eyal Karev

CEO, NIMedical Ltd

CEO

NIMedical Ltd

NIMedical is a biotechnology company, the world’s leading developer and manufacturer of whole body bioimpedance systems. The Non Invasive Cardiac System (NICaS) and the Hemodynamic Naviga...

Company Solutions

Our solution provides accurate management of Hemodynamic & Fluid parameters such as:

  • Stroke Volume
  • Cardiac Output
  • Total body water
  • Total peripheral resistance
  • And more

All of which are basic vital signs that enable physicians to better diagnose, treat and monitor their patients in a wide array of clinical applications.

As the traditional methods to measure these parameters require invasive procedures, such as Thermodilution or Fick that require insertion of a catheter, the use of these parameters is limited.

Our non-invasive technology, enables physicians, wherever they are, to measure and manage these parameters in a variety of settings including hospitals, clinics, and patients’ homes.

This leads to improved medical outcomes, both clinically and financially, in a wide variety of clinical applications, including:

  • Heart Failure management,
  • Hypertension control
  • Hemodialysis
  • Preeclampsia
  • Post-COVID19 management
  • Skilled Nursing Facilities
  • and more.

Looking For

  • Business partners/distributors network.
  • Home care organizations
  • Potential OEM
  • Hospitals, clinics and healthcare supply organizations
  • Strategic collaboration with leading Medical device / service providers, in the area of HF/CKD/Hypertension management